Table 1.
microRNAs | Expression in PH | Research object | Function in PH | Mechanisms | References |
---|---|---|---|---|---|
MiR-22 | reduced | animal | unknow | unknow | 25 |
miR-30 | reduced | animal | unknow | unknow | 25 |
let-7f | reduced | animal | unknow | unknow | 25 |
miR-21 | reduced | animal and human | unknow | unknow | 25 |
let-7a | reduced | animal | unknow | unknow | 25 |
miR-150 | reduced | human | protect | unknow | 27 |
miR-204 | reduced | animal and human | protect | target SHP2, inhibit PASMCs proliferation | 26 |
miR-322 | increased | animal | unknow | unknow | 25 |
miR-451 | increased | animal | unknow | unknow | 25 |
miR-210 | increased | animal | impair | Antiapoptotic effect in PASMCs | 29 |
miR-21 | increased | animal | impair | Enhanced the proliferation of human PASMCs | 31,32 |
miR-759 | increased | human | protect | Decrease the amount of total FGA mRNA via affecting the stability of FGA long isoform (aE) mRNA, which can contribute to CTEPH. | 35 |
miR-17/92, 20a | increased | animal | impair | STAT3-miR-17/92-BMPR2 pathway | 37,40 |
miR-145 | incerased | animal and human | impair | Inhibit the BMPR2 function | 38,39 |
miR-143 | increased | animal and human | impair | Prevents down-regulation of KLF4 and activation of contractile genes by TGF-β or BMP4 | 38 |
miR-17 | increased | animal | impair | up-regulation of p21 | 41 |
miR-206 | decreased | animal | protect | down regulating Notch-3 | 43 |
miR-328 | decreased | animal and human | protect | Inhibit L-type calcium channel-a1C expression | 44 |
miR-26a | decreased | animal and human | unknow | unknow | 28 |
miR-424 | decreased | animal | protect | FGF2 pathways | 42 |
miR-503 | decreased | animal | protect | FGF2 pathways | 42 |